PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Pharmacogenomics and Personalized Medicine · 2024-12 · Volume 17 · 611-621
DOI: 10.2147/pgpm.s490030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2024-12. Verfasst von Pengqiang Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fuwai Central China Cardiovascular Hospital, Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou Un…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Fuwai Central China Cardiovascular Hospital, Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450003, People's Republic of China.
- Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.
- Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, 450003, People's Republic of China.
- Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.
ORCID-Profile: Pengqiang Du, Xingang Li
Zitieren
APA
Du, P., Li, X., Li, D., Ma, Y., Ni, M., Li, Y., Li, W., Wang, A., & Xu, X. (2024). PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Pharmacogenomics and Personalized Medicine, Volume 17, 611-621. https://doi.org/10.2147/pgpm.s490030
Vancouver
Du P, Li X, Li D, Ma Y, Ni M, Li Y, et al. PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Pharmacogenomics and Personalized Medicine. 2024;Volume 17:611-621. doi:10.2147/pgpm.s490030
BibTeX
@article{Du2024,
author = {Du, Pengqiang and Li, Xingang and Li, Dandan and Ma, Yongcheng and Ni, Ming and Li, Yafei and Li, Wenbo and Wang, Aifeng and Xu, Xiaowei},
title = {PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2024},
volume = {Volume 17},
pages = {611--621},
doi = {10.2147/pgpm.s490030}
}
EUVIMED